A protest over a draft decision not to recommend a new cystic fibrosis drug is due later. Campaigners keen to see Kalydeco introduced across Wales are aiming to make their voices heard outside a meeting of the All Wales Medicines Strategy Group at the Angel Hotel in Abergavenny.
The group will look at the recommendation and decide whether to approve it or not. The drug - which is already available in England, Scotland and Northern Ireland - is the first licensed drug that treats the G551D mutation - the fundamental defect in those with cystic fibrosis.
More top news
The charity says the increase is partly due to people calling for help sooner, instead of attempting to rescue themselves.
Staying windy with occasional rain, sleet and snow showers and a risk of ice patches forming
A worker at Prince Charles Hospital in Merthyr Tydfil who stole NHS property and then sold it on eBay is given suspended jail sentence.